STOCK TITAN

Eargo Inc - EAR STOCK NEWS

Welcome to our dedicated news page for Eargo (Ticker: EAR), a resource for investors and traders seeking the latest updates and insights on Eargo.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Eargo's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Eargo's position in the market.

Rhea-AI Summary
Eargo, Inc. launches two new over-the-counter (OTC) hearing wellness devices, Eargo SE and LINK by Eargo, to provide customers with more choices to address hearing loss. The new devices offer a new earbud form factor and a completely-in-canal option focused on Eargo signature essentials, addressing additional consumer needs around functionality, design, and experience. Eargo's expanded portfolio ensures a breadth of options, no matter the level of need, and is available for purchase online, via Personal Hearing Guides, and in select retail partner stores.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.09%
Tags
none
-
Rhea-AI Summary
Eargo celebrates the one-year anniversary of the creation of an over-the-counter (OTC) hearing aid category in the US. The FDA's revised regulations aimed to reduce costs, increase competition, improve access, and drive innovation in the hearing aid category. Eargo actively supported the FDA's rulemaking. A recent survey of Eargo customers showed that OTC hearing aids are improving accessibility and adoption, with 70% of respondents being new to hearing aids. The average time from recognizing hearing loss to getting a hearing aid was 4 years, shorter than previous estimates. Eargo's virtually invisible and rechargeable hearing aids are unique in the market. The new OTC regulations allow for broader marketing and sales, making hearing aids more affordable and accessible.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.92%
Tags
none
-
Rhea-AI Summary
Eargo expands its relationship with Best Buy, with Eargo devices now available in over 500 Best Buy stores. Approximately 250 locations will carry Eargo 5, an FDA-cleared self-fitting hearing aid. Customers can also explore Eargo's full assortment of hearing aids on BestBuy.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
none
Rhea-AI Summary
Eargo, Inc. reports net revenues of $8.1 million in Q2 2023, up 12% YoY. Gross systems shipped increase by 14% YoY. GAAP total operating loss of $25.8 million. Cost reduction plan expected to extend net operating cash runway into H2 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.02%
Tags
-
Rhea-AI Summary
Eargo reports Q1 2023 financial results, with net revenues of $11.8 million, up 29% YoY. Gross systems shipped increased 51% YoY. GAAP total operating loss was $22.8 million. Eargo 7 self-fitting hearing aid launched in February 2023. Company expects modest sequential improvements to net operating cash burn in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.17%
Tags
-
Rhea-AI Summary
Eargo, Inc. (Nasdaq: EAR) will release financial results for Q1 2023 on May 11, 2023, followed by a conference call and webcast to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.88%
Tags
conferences earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.83%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.47%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.84%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
none
Eargo Inc

Nasdaq:EAR

EAR Rankings

EAR Stock Data

53.36M
19.64M
5.43%
6.39%
0.2%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States
San Jose

About EAR

we’re eargo. a company made up of ent surgeons, tech geeks and dreamers, united in our belief that people should be able to hear life to the fullest. because the world is full of great things to hear. and because, well, we really like people. it's because we like people that we do what we do. we want the best for them, and this is our way to make sure they get it (we also like pina coladas, cuddly puppies and long walks on the beach, in case you’re wondering). we don't believe that caring for your hearing health should come at the cost of compromising your lifestyle or appearance. that's why we’ve created devices that work superbly, are easy to use and – because of our patented flexi fibers – are incredibly comfortable and essentially invisible. we start with the user, the person who's going to open the eargo box with eager anticipation, and build all of our products and experiences in ways that make them feel understood and cared for. that pays off their eager anticipation. we feel th